Recap: Amryt Pharma Q1 Earnings

Amryt Pharma AMYT reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Amryt Pharma missed estimated earnings by 150.0%, reporting an EPS of $-0.05 versus an estimate of $-0.02.

Revenue was up $10.70 million from the same period last year.

Last quarter the company beat on EPS by $0.08 which was followed by a 4.7% drop in the share price the next day.

Here's a look at Amryt Pharma's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-0.15	-0.17	0.19	0.13
EPS Actual	-0.07	-0.07	-0.04	-0.09
Revenue Estimate	56.81M	52.78M	50.49M	46.15M
Revenue Actual	54.83M	56.52M	62.76M	48.43M

To track all earnings releases for Amryt Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.